Key statistics
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.00 |
---|---|
High | 0.00 |
Low | 0.00 |
Bid | -- |
Offer | -- |
Previous close | 0.00 |
Average volume | -- |
---|---|
Shares outstanding | 17.04m |
Free float | 16.63m |
P/E (TTM) | -- |
Market cap | 58.10m USD |
EPS (TTM) | -10.35 USD |
Data delayed at least 15 minutes, as of Nov 16 2023 07:15 GMT.
More ▼
Announcements
- Mural Oncology to Present Clinical and Preclinical Data at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
- Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Mural Oncology’s First Virtual Investor Day to Highlight Late-Stage Clinical Progress
- Mural Oncology Strengthens Board of Directors with the Appointment of Sachiyo Minegishi
- Mural Oncology to Host First Virtual Investor Day on September 26, 2024
- Mural Oncology to Present at Two Upcoming Investor Conferences
- Mural Oncology Announces Second Quarter 2024 Financial Results and Provides Update on Pipeline Progress
- Mural Oncology Appoints Veteran Business Development Executive George Golumbeski, Ph.D., to its Board of Directors
- Mural to Present and Host 1x1 Investor Meetings at the 14th Annual East Coast IDEAS Investor Conference
- Mural Oncology Presents Clinical Data from ARTISTRY-3 at the American Society of Clinical Oncology Annual Meeting
More ▼